J&J to buy Alios BioPharma for $1.75 billion By: MarketWatch September 30, 2014 at 09:23 AM EDT Alios’ portfolio includes a treatment for infants with respiratory syncytial virus. Read More >> Related Stocks: Johnson & Johnson Macy's